Skip to content
TrialScanner

NCT02726334

A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.

Phase 1TerminatedNEUPLead

Registry record

Lead sponsor
Bionomics Limited
Conditions
Colorectal Cancer
Primary completion
Dec 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02726334 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02726334: A Phase I, Dose Escalation... | TrialScanner